Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Gross Margin (2018 - 2026)

Health Catalyst filings provide 9 years of Gross Margin readings, the most recent being 50.12% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 449.0% to 50.12% in Q1 2026 year-over-year; TTM through Mar 2026 was 67.55%, a 2231.0% increase, with the full-year FY2025 number at 48.75%, up 283.0% from a year prior.
  • Gross Margin hit 50.12% in Q1 2026 for Health Catalyst, down from 52.74% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 83.64% in Q2 2025 to a low of 51.9% in Q4 2023.
  • Median Gross Margin over the past 5 years was 52.74% (2025), compared with a mean of 49.15%.
  • Biggest five-year swings in Gross Margin: plummeted -5741bps in 2022 and later skyrocketed 6117bps in 2024.
  • Health Catalyst's Gross Margin stood at 9.75% in 2022, then plummeted by -432bps to 51.9% in 2023, then skyrocketed by 118bps to 9.27% in 2024, then soared by 469bps to 52.74% in 2025, then dropped by -5bps to 50.12% in 2026.
  • The last three reported values for Gross Margin were 50.12% (Q1 2026), 52.74% (Q4 2025), and 81.18% (Q3 2025) per Business Quant data.